US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

672.36

+10.431.58%

Number of Gainers:93

Number of Losers:52

Number of Flat:8

PE:- -

High:672.79

Open:662.15

Low:661.43

Close:662.00

Volume:143.07M

Turnover:3.78B

Market Cap:464.96B

Float Cap:357.47B

Loading ...

Rani Therapeutics RaniPill Platform Joins FDA Emerging Technology Program

FTC Solar - Q1 2027 Adj Ebitda Covenant Set at $2 Mln

THOMSON REUTERS

FTC Solar - $5 Mln Cash Repayment Deferred to March 31, 2027

THOMSON REUTERS

FTC Solar - no Financial Covenants Apply for Q3 and Q4 2026

THOMSON REUTERS

FTC Solar - Full-Year 2026 Adj Ebitda Covenant Removed

THOMSON REUTERS

FTC Solar Announces Waiver and Amendment to Credit Agreement

THOMSON REUTERS

FTC Solar - Future Cash Balance Covenant Adjusted to $15 Mln, Tested from January 4, 2027

THOMSON REUTERS

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (Etp)

THOMSON REUTERS

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

Analysts Offer Insights on Technology Companies: Shift4 Payments (FOUR), Enphase Energy (ENPH) and Zeta Global Holdings Corp (ZETA)

Karooooo Updates Financial Calendar for Second-Quarter 2027 Results Release

Krispy Kreme Updates Financial Calendar with Third-Quarter 2026 Results Release and Conference Call

Jiuzi Holdings Maintains Expectation of About Us$1.55 Million Profit from Initial AI Platform Cooperation Stage

AstraZeneca completes $2B equity investment in Summit Therapeutics

Analysts Offer Insights on Financial Companies: GCM Grosvenor (GCMG) and Robinhood (HOOD)

3 High Growth Companies With Significant Insider Ownership

Simply Wall St.

Invivyd Grants Options for 157,500 Shares to Six New Hires Under 2026 Inducement Plan

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Invivyd Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4539/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":672.42505,"timestamp":1791565627672,"preClose":661.99634,"halted":0,"volume":142986100,"delay":0,"changeRate":0.015753,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":10.428711,"latestTime":"10-09 13:07:07 EDT","open":662.1523,"high":672.794,"low":661.43115,"amount":3783669827.287213,"amplitude":0.017165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.138586,"peRate":113.608055,"turnoverRate":0.011204,"increases":92,"decrements":52,"flats":6,"marketCap":464955949419.3125,"floatMarketCap":357474887314.71875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":672.794,"amplitude":0.017165,"preClose":661.99634,"low":661.43115,"pbRate":"5.138586","latestPrice":672.36414,"volume":143073504,"delay":0,"open":662.1523,"prevYearClose":881.5255,"prevWeekClose":665.7447,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":665.7447,"twentyDayClose":693.0266,"sixtyDayClose":732.057,"secType":"PLATE","market":"US","turnoverRate":0.011211,"peRate":113.608055,"marketCap":464913030455.3125,"floatMarketCap":357436221478.71875,"timestamp":1791565632119,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":93,"down":52,"flat":8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673702734","title":"Rani Therapeutics RaniPill Platform Joins FDA Emerging Technology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702734?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:11","pubTimestamp":1791202291,"startTime":"0","endTime":"0","summary":"Rani Therapeutics RaniPill platform joins FDA Emerging Technology ProgramRani Therapeutics’ RaniPill Capsule platform was accepted into the FDA’s Emerging Technology Program under CDER.Acceptance enab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL5Fp4MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4007","IE00BQXX3D17.EUR","SG9999014021.USD","SG9999014039.USD","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","BK4112","RANI","BK4585","SG9999014013.SGD","BK4588","BK4539","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673781702","title":"FTC Solar - Q1 2027 Adj Ebitda Covenant Set at $2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2673781702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673781702?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:01","pubTimestamp":1791201660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA9JSRBH:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4096","FTCI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702276","title":"FTC Solar - $5 Mln Cash Repayment Deferred to March 31, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702276?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:01","pubTimestamp":1791201660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA9JSRBH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTCI","BK4096","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702273","title":"FTC Solar - no Financial Covenants Apply for Q3 and Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702273?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:01","pubTimestamp":1791201660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA9JSRBH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTCI","BK4096","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702222","title":"FTC Solar - Full-Year 2026 Adj Ebitda Covenant Removed","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702222?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:01","pubTimestamp":1791201660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA9JSRBH:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTCI","BK4539","BK4096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702157","title":"FTC Solar Announces Waiver and Amendment to Credit Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702157?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:01","pubTimestamp":1791201660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA9JSRBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4096","BK4539","FTCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022757","title":"FTC Solar - Future Cash Balance Covenant Adjusted to $15 Mln, Tested from January 4, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022757?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:01","pubTimestamp":1791201660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA9JSRBH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4096","BK4539","FTCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702941","title":"Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (Etp)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702941?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201629,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R04A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4007","RANI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702771","title":"Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702771?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201600,"startTime":"0","endTime":"0","summary":"Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, co","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374474/18623/en/marea-therapeutics-a-subsidiary-of-lisata-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-mar002-a-potential-best-in-disease-investigational-therapy-for-the.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","ENDO","BK4551","KBWY","GNOM","PTH","LU0889565916.HKD","LU0320765992.SGD","PK","BK4585","GH","BK4007","EKG","HELX","LENZ","FFOX","BK4588","BK4196","LFSC","LU0109394709.USD","BK4218","BK4181","BK4183","GNMX","GDOC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702726","title":"Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702726","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702726?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201600,"startTime":"0","endTime":"0","summary":"~ Acceptance into ETP enables early FDA engagement to support development of the RaniPill platform technology ~SAN JOSE, Calif., Oct.  05, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Na","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374470/0/en/rani-therapeutics-announces-acceptance-into-u-s-fda-s-emerging-technology-program-etp.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","LENZ","BK4588","BK4539","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702981","title":"Analysts Offer Insights on Technology Companies: Shift4 Payments (FOUR), Enphase Energy (ENPH) and Zeta Global Holdings Corp (ZETA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702981?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:50","pubTimestamp":1791201012,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Shift4 Payments (FOUR), Enphase Energy (ENPH) and Ze...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-shift4-payments-four-enphase-energy-enph-and-zeta-global-holdings-corp-zeta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-shift4-payments-four-enphase-energy-enph-and-zeta-global-holdings-corp-zeta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENPH","LU0719512351.SGD","TAN","BK4613","IE00BN0W2V16.EUR","BK4539","TECS","ARTY","ICLN","LU2125909916.SGD","LU0823414551.USD","ZETX","VCLN","LU2249611893.SGD","BK4147","IE00BFMHRM44.USD","LU1720051017.SGD","BK4596","LU1548497426.USD","IE0009354923.USD","LU2357305700.SGD","LU0823414478.USD","LU1720051108.HKD","ZETA","LU2125909759.SGD","LU0082616367.USD","LU2294711713.HKD","LU2357125470.USD","IE00BN0W2T93.GBP","BK4585","LU1861217088.USD","LU1923622291.USD","LU2360107671.USD","IE00BN0W2W23.USD","LU1861220207.SGD","LU1878469433.USD","BK4106","FOUR","BK4227","ENPX","LU2506951792.HKD","STBQ","LU1983299162.USD","BK4588","LU0348723411.USD","CTEC","WATS","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702346","title":"Karooooo Updates Financial Calendar for Second-Quarter 2027 Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702346","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702346?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:47","pubTimestamp":1791200868,"startTime":"0","endTime":"0","summary":"Karooooo updates financial calendar for second-quarter 2027 results releaseKarooooo will release second-quarter fiscal 2027 financial results on Oct. 19, 2026, shortly after 4:00 p.m. ET.A results web","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL5fb3sy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","KARO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673170475","title":"Krispy Kreme Updates Financial Calendar with Third-Quarter 2026 Results Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2673170475","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673170475?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:30","pubTimestamp":1791199817,"startTime":"0","endTime":"0","summary":"Krispy Kreme updates financial calendar with third-quarter 2026 results release and conference callKrispy Kreme will release fiscal third-quarter 2026 earnings on Nov. 5, 2026, with materials posted a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL5TP6h3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4209","BK4539","BK4588","DNUT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704990","title":"Jiuzi Holdings Maintains Expectation of About Us$1.55 Million Profit from Initial AI Platform Cooperation Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704990?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:15","pubTimestamp":1791198915,"startTime":"0","endTime":"0","summary":"Jiuzi Holdings maintains expectation of about US$1.55 million profit from initial AI platform cooperation stageJiuzi forecast about USD 1.55 million profit from the initial stage of its AI smart imagi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL6QN7Kh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014039.USD","IE00BQXX3F31.USD","JZXN","BK4112","IE00BN0W2T93.GBP","BK4588","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","LU2210150020.SGD","BK4214","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014013.SGD","SG9999014021.USD","LU2095319765.USD","BK4539","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044487","title":"AstraZeneca completes $2B equity investment in Summit Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044487","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044487?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:12","pubTimestamp":1791198767,"startTime":"0","endTime":"0","summary":"Summit Therapeutics (SMMT) announced the successful closing of AstraZeneca’s (AZN) strategic equity investment in Summit. The equity investment wil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-completes-2b-equity-investment-in-summit-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-completes-2b-equity-investment-in-summit-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443622.USD","LU0708994859.HKD","LU0128525929.USD","BK4539","LU0109394709.USD","IE00B3T34201.USD","LU2237443382.USD","LU2417539215.USD","LU1829250122.USD","LU2089984988.USD","AZNH","BK4588","LU2236285917.USD","LU0320765992.SGD","LU2237443895.HKD","LU2237443465.HKD","LU2468319806.SGD","BK4007","LENZ","LU2237443549.SGD","LU0432979614.USD","LU0289739699.SGD","LU2488822045.USD","LU1267930573.SGD","BK4568","BK4585","LU2462157665.USD","LU0889565916.HKD","BK4139","LU2237443978.SGD","SMMT","LU0310800379.SGD","LU0029864427.USD","LU2456880835.USD","AZN","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673670444","title":"Analysts Offer Insights on Financial Companies: GCM Grosvenor (GCMG) and Robinhood (HOOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673670444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673670444?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:11","pubTimestamp":1791198682,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on GCM Grosvenor (GCMG) and Robinhood (HOOD) with bullis...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-financial-companies-gcm-grosvenor-gcmg-and-robinhood-hood-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-financial-companies-gcm-grosvenor-gcmg-and-robinhood-hood-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FINX","IAI","BK4539","GCMG","LU1861559042.SGD","BPAY","HOOD","HOOG","HODU","ROBN","BK4547","HOOZ","BLCK","HOII","BK4127","HOOC","LU1861558580.USD","HOOW","HOOX","HOYY","HOOY","CRPT","HOOI","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704729","title":"3 High Growth Companies With Significant Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704729","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704729?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:05","pubTimestamp":1791198334,"startTime":"0","endTime":"0","summary":"The market in the United States has remained flat over the past week, yet it has experienced a 12% increase over the last year, with earnings projected to grow by 18% annually. In this environment, identifying growth companies with substantial insider ownership can be advantageous as it often indicates strong confidence from those closest to the business and potential alignment of interests with shareholders.","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/fallback-card/1788935129352","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/fallback-card/1788935129352"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nyse-pay/paymentus-holdings/news/3-high-growth-companies-with-significant-insider-ownership-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nyse-pay/paymentus-holdings/news/3-high-growth-companies-with-significant-insider-ownership-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4528","BK4532","BK4548","LU0050427557.USD","LU0086394185.USD","LU0823046494.USD","LU0106259046.USD","LU1144417596.USD","LU2125910500.SGD","LU2357305700.SGD","LU1868837565.USD","LU0254981946.USD","BK4561","BK4613","LU0143863198.USD","LU0143863784.USD","LU0210535034.USD","LU0531970944.HKD","BK4559","LU0251143458.SGD","LU0265266980.USD","LU0449509016.USD","IE0009356076.USD","LU0456842615.SGD","LU0256859116.SGD","LU0265267285.USD","LU0823046577.USD","LU1720051108.HKD","NUG","BK4566","LU1720051017.SGD","LU0196696453.USD","BK4106","IE00BGV7N243.SGD","BK4607","BK4207","LU0048575426.USD","LU1548497426.USD","LU1481012133.USD","LU1861220207.SGD","GB00BDT5M118.USD","PAY","BK4585","LU0572108347.SGD","IE00B1B80R65.USD","LU0531971322.HKD","LU1861217088.USD","BK4023","BK4227","LU2360107671.USD","TEAM","NU","LU0261950470.USD","LU0214875030.USD","BK4539","LU0396314238.USD","LU1868838027.USD","LU2045819591.USD","BK4588","LU0196696701.USD","LU0053687314.USD","LU0072463663.USD","LU0788109048.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704510","title":"Invivyd Grants Options for 157,500 Shares to Six New Hires Under 2026 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704510?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:05","pubTimestamp":1791198307,"startTime":"0","endTime":"0","summary":"Invivyd grants options for 157,500 shares to six new hires under 2026 inducement planInvivyd granted stock options covering 157,500 shares to six newly hired non-executive employees on Oct. 1, 2026.Ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL1pJhrq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","BK4585","BK4139","LU2210150020.SGD","BK4112","BCDF","IE00B3QW5Z07.USD","IVVD","IE00BQXX3F31.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4539","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704197","title":"Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704197","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704197?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:05","pubTimestamp":1791198300,"startTime":"0","endTime":"0","summary":"ATH434 50 mg significantly slowed functional decline in MSA by approximately 52% versus placebo on the 11-item UMSARS at Week 52 with CSF NfL as a covariate Baseline CSF NfL predicted the rate of func","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374418/0/en/alterity-therapeutics-presents-new-analyses-of-ath434-phase-2-data-in-multiple-system-atrophy-at-the-2026-international-congress-of-parkinson-s-disease-and-movement-disorders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU2125909916.SGD","LU2211815571.USD","LU0154245756.USD","LENZ","LU0728928796.USD","MSA","CSF","LU1815336091.USD","BK4139","LU0757428866.USD","LU2125909759.SGD","ATHE","LU1923622291.USD","BK4539","BK4007","BK4143","LU0154245673.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673823704","title":"Invivyd Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673823704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673823704?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:01","pubTimestamp":1791198060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA8HTKXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":14,"totalSize":782,"code":"91000000","status":"200"}]}}